Abstract
The aim of the present study is to investigate the potential influence of obesity as a factor in 5- hydroxytryptamine (5-HT) concentration in myxomatous mitral valve disease (MMVD) dogs. Fifty-five client-owned dogs were enrolled in a randomized trial. Dogs were classified by echocardiography into healthy (control), mild, and moderate to severe MMVD groups. Each group was subclassified by using a 9-point body condition score (BCS); lean (BCS 5-6/9) and obese groups (BCS 7.5-9/9). Dogs with moderate to severe MMVD had lower serotonin (5- HT) concentrations than the control group (p = 0.03). Dogs with moderate to severe MMVD (p = 0.017) had lower serum 5-HT concentrations than the control group in the obese group (BCS 7.5-9/9). Significant difference was found between the lean and obese groups (p = 0.015) which are not consider severe in the MMVD group. These results suggested that 5-HT concentration was decreased with the increasing severity of MMVD, and obesity might be taken into consideration when interpreting the serotonin concentration in MMVD dogs.
Original language | English (US) |
---|---|
Pages (from-to) | 205-208 |
Number of pages | 4 |
Journal | Korean Journal of Veterinary Research |
Volume | 56 |
Issue number | 4 |
DOIs | |
State | Published - Jan 1 2016 |
Externally published | Yes |
Keywords
- 5-HT concentration
- Body condition score
- Dogs
- Myxomatous mitral valve disease
- Obesity
ASJC Scopus subject areas
- veterinary(all)